#Pyrosequencing Market Size | Explore Tumblr posts and blogs

sueheaven · 2 years ago

Text

Precision Medicine market Is Likely to Experience a Tremendous Growth in Near Future

Latest business intelligence report released on Global Precision Medicine Market, covers different industry elements and growth inclinations that helps in predicting market forecast. The report allows complete assessment of current and future scenario scaling top to bottom investigation about the market size, % share of key and emerging segment, major development, and technological advancements. Also, the statistical survey elaborates detailed commentary on changing market dynamics that includes market growth drivers, roadblocks and challenges, future opportunities, and influencing trends to better understand Precision Medicine market outlook. List of Key Players Profiled in the study includes market overview, business strategies, financials, Development activities, Market Share and SWOT analysis are:

Biocrates Life Sciences AG (Austria)

Nanostring Technologies (United States)

Intomics (Denmark)

Pfizer Inc. (united States)

Eagle Genomics Ltd (United Kingdom)

Teva Pharmaceuticals (Israel)

Laboratory Corporation of America Holdings (United States)

Novartis AG (Switzerland)

Qiagen NV (Netherlands)

Quest Diagnostics Incorporated (United States)

F. Hoffmann-La Roche AG (Switzerland)

Precision Medicine is refer to customization of medical treatment by genetic understanding of the patients. It is use to analyze cause of disease at molecular level. New technologies in precision medicine market like genome sequencing, targeted sequencing and continuous research and development owing to increasing number of cancer and rare diseases growing the market. In addition development in personalized treatment, cost- effective therapies are projected to drive the sales potentially over forecast period. Key Market Trends: Growing cost-effective genomic and molecular biology testing techniques Opportunities: Growing Research in Big Pharma and Biotech Companies Market Growth Drivers: Growing incidence of cancer and rare diseases

Increasing Use of Big Data in Healthcare

Rising Demand of Personalized Treatment

Challenges: Intense Competition among the vendors The Global Precision Medicine Market segments and Market Data Break Down by Type (Consumables, Instruments, Services, Others), Application (Diagnostics, Therapeutics, Pharmaceuticals, Medical Devices, Others), End User (Diagnostic Tool companies, Pharma & Biotech Companies, Clinical Laboratories, Healthcare, IT/Big Data Companies), Technology (Genomics, Transcriptomics, Epigenomics), Sequencing (Sequencing by Synthesis, Ion Semiconductor Sequencing, Sequencing by Ligation, Pyrosequencing, Single Molecule Real Time Sequencing, Chain Termination Sequencing, Nanopore Sequencing)

Presented By

AMA Research & Media LLP

0 notes

rdagade · 3 years ago

Text

Global DNA Sequencing Market: Scope, Share, Future, Opportunity, Driver, Status, Forecast to 2027

DNA Sequencing Market Overview: Maximize Market Research has Published an intelligence report entitled Global DNA Sequencing Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2027 that is the complete creation of meticulous primary and secondary research. The report thoroughly covers analysed insights in view of the market along with its ever-changing patterns, industry environment, and all dominant aspects of the market. This research methodology has been applied to examine the global DNA Sequencing market and these findings have been logically mentioned in this report. Request For Free Sample: https://www.maximizemarketresearch.com/request-sample/21790

Market Scope:

Global DNA Sequencing Market 2021 research report 2027 provides vital statistics and analytical knowledge to grant an entire understanding of the market size, share, growth, trend, demand, top player and industry summary, opportunities, worth cycle, end-users, technology, types and application. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The qualitative and quantitative data provided in the DNA Sequencing market study can help decision-makers understand which market segments, regions are expected to grow at higher rates, factors affecting the market, and key opportunity areas. The report also includes the competitive landscape of key players in the industry along with emerging trends in the DNA Sequencing market. PESTEL Analysis: The reports provided by Maximize Market Research provide PESTEL analysis to help you shape your business strategy. Political factors such as taxation, environmental regulations and tariffs help governments determine the extent to which they can influence the DNA Sequencing market. Economic factors such as interest rates, exchange rates, inflation and wage rates, and minimum wages can help you analyze the determinants of economic performance that affect the DNA Sequencing market. Legal factors help us understand the impact of environmental impacts and consideration on the market. Segmentation:

DNA Sequencing Market

Report CoverageDetails

Base Year:2020Forecast Period:2021-2027

Historical Data:2016 to 2020Market Size in 2020:US $ 4.80 Bn.

Forecast Period 2021 to 2027 CAGR:11.4 %Market Size in 2027:US $ 10.22 Bn.

Segments Covered:by Product• Consumables • Instruments • Services

by Application• Biomarkers & Cancer • Diagnostics • Reproductive Health • Personalized Medicine • Forensics

by Technology• Sequencing by synthesis • Ion semiconductor sequencing • Sequencing by ligation • Pyrosequencing • Single-molecule-real-time sequencing • Chain termination sequencing • Nanopore sequencing

by End-User• Academic & government research institutes • Pharmaceutical companies • Biotechnology companies • Hospitals & Clinics

Key Players:

• ZS Genetics • Siemens AG • Pacific Biosciences • Myriad Genetics • Microchip Biotechnologies • Johnson & Johnson • Integrated DNA Technologies • Hamilton Thorne Biosciences • Commonwealth Biotechnologies • Bayer Corporation • Agilent Technologies • Abbott Laboratories • Abbott Laboratories • LI-COR Biosciences • GE Healthcare Life Sciences • 454 Life Sciences • Illumina, Inc. • QIAGEN • Perkin Elmer • Thermo Fisher • Macrogen, Inc. The competitive landscape is a critical aspect every key player needs to be familiar with. The report throws light on the competitive scenario of the global DNA Sequencing market to know the competition at both the domestic and global levels. The key aspects such as areas of operation, production, and product portfolio. Additionally, companies in the report are studied based on key factors such as company size, market share, market growth, revenue, production volume, and profits. In additional DNA Sequencing Market Share analysis of players, in-depth profiling, product/service and business overview, the study also concentrates on BCG matrix, heat map analysis, Competitive Benchmarking along with SWOT analysis to better correlate market competitiveness. Get more Report Details: https://www.maximizemarketresearch.com/market-report/global-dna-sequencing-market/21790/

Regional Analysis:

Geographically, this report is segmented into several key countries, with market size, growth rate, import and export of DNA Sequencing market in these countries, which covering North America, U.S., Canada, Mexico, Europe, UK, Germany, France, Spain, Italy, Rest of Europe, Asia Pacific, China, India, Japan, Australia, South Korea, ASEAN Countries, Rest of APAC, South America, Brazil, and Middle East and Africa. COVID-19 Impact Analysis on DNA Sequencing Market: The report has identified detailed impact of COVID-19 on DNA Sequencing market in regions such as North America, Asia Pacific, Middle-East, Europe, and South America. The report provides Comprehensive analysis on alternatives, difficult conditions, and difficult scenarios of DNA Sequencing market during this crisis. The report briefly elaborates the advantages as well as the difficulties in terms of finance and market growth attained during the COVID-19. In addition, report offers a set of concepts, which is expected to aid readers in deciding and planning a strategy for their business. Key Questions answered in the DNA Sequencing Market Report are: Which product segment grabbed the largest share in the DNA Sequencing market? How is the competitive scenario of the DNA Sequencing market? Which are the key factors aiding the DNA Sequencing market growth? Which region holds the maximum share in the DNA Sequencing market? What will be the CAGR of the DNA Sequencing market during the forecast period? Which application segment emerged as the leading segment in the DNA Sequencing market? Which are the prominent players in the DNA Sequencing market? What key trends are likely to emerge in the DNA Sequencing market in the coming years? What will be the DNA Sequencing market size by 2027? Which company held the largest share in the DNA Sequencing market? About Us: Maximize Market Research provides B2B and B2C research on 12000 high growth emerging opportunities technologies as well as threats to the companies across the Healthcare, Pharmaceuticals, Electronics Communications, Internet of Things, Food and Beverages, Aerospace and Defence and other manufacturing sectors. Contact Us: MAXIMIZE MARKET RESEARCH PVT. LTD. 3rd Floor, Navale IT Park Phase 2, Pune Bangalore Highway, Narhe, Pune, Maharashtra 411041, India. Phone No.: +91 20 6630 3320

0 notes

strangecatinternet · 4 years ago

Text

MARKET ANALYSIS & SEGMENT FORECAST FROM 2021 TO 2028 GLOBAL NEXT-GENERATION SEQUENCING (NGS) MARKET

Global Next Generation Sequencing Market Size, Share & Trends Analysis Report By Sequencing (Whole Genome, Targeted Resequencing, Whole Exome, RNA, CHIP, DE Novo, Methyl), By Technology (Sequencing By Synthesis, ION Semiconductor, SMRT, Nanopore, Others), By Product (Reagents and Consumables, Software and Services), By Applications (Drug discovery and Personalized Medicine, Diagnostics and Genetic Screening, Agriculture and Animal Research, Others), By End-User (Academic institutes and Research Centre, Hospitals and Clinics, Pharma and Bio-Technology Companies, Others), By Region And Segment Forecasts, 2021 - 2028

The report covers the following major segments of the Next-Generation Sequencing market:

By Sequencing: Whole Genome Sequencing, Targeted Resequencing, Whole Exome Sequencing, RNA Sequencing, CHIP Sequencing, De Novo Sequencing, and Methyl Sequencing

By Technology: Sequencing by Synthesis, Ion Semiconductor Sequencing, Single-Molecule Real-Time Sequencing, Nanopore Sequencing, and Others (Polony sequencing, pyrosequencing, DNA nano ball sequencing, and true Single Molecule Sequencing (tSMS)

By Products: Instruments, Reagents and Consumables, and Software and Services

By Applications: Drug Discovery and Personalized Medicine, Genetic Screening, Diagnostics, Agriculture and Animal Research, and Others

By End-Use: Academic Institutes and Research Centre, Hospitals and Clinics, Pharmaceutical and Biotechnology Companies, and Others

By Region: North America, Europe, Asia-Pacific, South America, and META

Regional Scope

The report covers five regions including North America, Europe, Asia-Pacific, South America, and ME&A. Each region is segregated by countries, which include North America (USA, Canada, Mexico), Europe (UK, Germany, France, Spain, Italy, and Rest of Europe), Asia-Pacific (India, China, Japan, and the Rest of Asia-Pacific), South America (Brazil, Rest of South America), ME&A (the Middle East and Africa). These are the countries throughout the world where the robust growth of next-generation sequencing market adoption was observed in the past and is expected to register growth during the forecast period due to the increasing adoption of advanced infrastructures and rising demand for sequencing in almost all the healthcare sectors. Also, key drivers of all the countries are included in the report which indicates the favorable opportunities for companies to enter these markets.

Estimates and Forecast Analysis

The report covers market estimations and projections of Global Next-Generation Sequencing for the following years:

Base year: 2020

Projected years: 2021-2028

The key industry dynamics, major technological trends, and application markets have been evaluated to understand their impact on demand for the forecast period. The growth rates were estimated using correlation, regression, and time-series analysis

We have used the bottom-up approach for market sizing, analyzing key regional markets, dynamics, and trends for various products, sequences, and end-uses. The global market has been estimated by integrating the regional and application markets

All market estimates and forecasts have been validated through primary interviews with the key industry participants

Inflation has not been accounted for to estimate and forecast the market

Numbers may not add up due to rounding off

Global Next-Generation Sequencing Market – Key Industry Insights

The global market for Next-Generation Sequencing is growing with revenue of USD 8,767.9 Million in 2020, and it is expected to witness a CAGR of 17.2% during the period 2021-2028.

Among the various application, the diagnostics and genetic screening segment held the largest share of XX%, with a value of USD XX Million in 2020 and it is expected to grow with a CAGR of XX% to reach USD XX Million in 2028.

Out of end-users, the academic institutes and research center segment held the largest share of XX%, with a value of USD XX Million in 2020 and it is expected to grow with a CAGR of XX% to reach USD XX Million in 2028.

Among the sequencing methods, the targeted resequencing segment held the largest share of XX%, with a value of USD XX Million in 2020 and it is expected to grow with a CAGR of XX% to reach USD XX Million in 2028.

Among the various technologies, the sequencing by synthesis segment held the largest share of XX%, with a value of USD XX Million in 2020 and it is expected to grow with a CAGR of XX% to reach USD XX Million in 2028.

Among the product types, the reagents and consumables segment held the largest share of XX%, with a value of USD XX Million in 2020 and it is expected to grow with a CAGR of XX% to reach USD XX Million in 2028.

Among the five regions including North America, Europe, Asia-Pacific, South America, and ME&A, the North American market held the largest share of XX%, with the value at USD XX Million in 2020 and it is expected to grow with a CAGR of XX% to reach USD XX Million in 2028.

Global Next-Generation Sequencing Market – Key Market Developments

📷

Global Next-Generation Sequencing Market - Drivers

📷

Decreasing costs for genetic sequencing with advancement in the field of genomics: As genomics continues to improve and associated costs decline, the use of next-genome sequencing has become more broadly adopted and integrated into daily clinical applications. According to the National Human Genome Research Institute (NHGRI), the cost of genomic sequencing has reduced to a significant amount from USD 95 million per genome in 2001 to USD 689 per genome in 2020, with the continuous expansion of research in human genetics and the increase in the number of clinical applications of genome sequencing. The cost of genetic sequencing started to fall after the introduction of the "second generation" (or "next-generation") sequencing platform in 2008. Before next-generation, Sanger-based chemical reagents, and capillary-based instruments ("first generation" sequencing platforms) were used to generate DNA sequences. The change in the instruments provides rapid development of DNA sequencing technology in recent years.

📷

Exponential advancements in science and technology are revolutionizing the ability to decode the human genome to understand disease risks and customize treatments. The improvements in diagnostic scanning and in-vitro testing help in providing more information regarding human anatomy and also provides precision medicine and evidence-based approaches in clinical trials and thus, reducing the cost of genome sequencing.

COVID-19 Impact Analysis

The year 2020 marked a watershed moment in both history and global health. The COVID-19 pandemic has brought attention to the dangers of lethal epidemic-prone diseases sweeping our globalized world. COVID-19 has resulted in incalculable tragedy, but it has also demonstrated how science may adapt when confronted with a big global emergency. Over the last decade, a technological revolution has brought various new capabilities for pandemic response. One of them is the development of vaccinations at breakneck speed. Another example is genomic sequencing.

The world was able to swiftly detect SARS-CoV-2 with the assistance of sequencing (Next-generation sequencing Technology) and realizing that when the genome sequencing process was taking into account the speed with which diagnostic tests and other reaction devices might be developed quickly. Consistent genome sequencing helps with the tracking of disease transmission, movement, and development.

Next Generation Sequencing (NGS) Market Segmentation

Next Generation Sequencing (NGS) Market, By OfferingWhole Genome Sequencing (WGS) Targeted Resequencing Whole Exome Sequencing (WES) RNA Sequencing CHIP Sequencing De Novo Sequencing Methyl Sequencing

Next Generation Sequencing (NGS) Market, By TechnologySequencing By Synthesis (SBS) Ion Semiconductor Sequencing Single-Molecule Real-Time Sequencing (SMRT) Nanopore Sequencing Other Technologies

Next Generation Sequencing (NGS) Market, By ProductReagents and Consumables Software and Services

Next Generation Sequencing (NGS) Market, By ApplicationDrug Discovery and Personalized Medicine Diagnostics and Genetic Screening Agriculture and Animal Research Others

Next Generation Sequencing (NGS) Market, By End-UserAcademic Institutes and Research Center Hospitals and Clinics Pharmaceutical and Biotechnology Companies Others

Next Generation Sequencing (NGS) Market, By Region North AmericaUSA Canada Mexico Asia-PacificChina India Japan Rest of Asia-Pacific EuropeUK Germany France Spain Italy Rest of Europe South AmericaBrazil Rest of South America ME&AMiddle East Africa

Company Profiles

ILLUMINA INC.

THERMO FISHER SCIENTIFIC

PERKINELMER

F. HOFFMANN-LA ROCHE AG (ROCHE)

PACIFIC BIOSCIENCES

AGILENT TECHNOLOGIES

10X GENOMICS INC

QIAGEN

Report AttributeDetailsMarket size value in 2020USD 8,767.9 MnRevenue forecast in 2028USD XX MnGrowth rateCAGR of 17.2% from 2021 to 2028Base year for estimation2020Forecast period2021-2028Quantitative unitsRevenue in USD million and CAGR from 2021 to 2028Report coverageMarket Size by Region, Revenue Size, Company Profiles, KOL Commentary, SWOT, Porter's Five Forces, Growth Factors, and TrendsSegments coveredBy Sequencing, By Technology, By Products, By Application, By End-Use, By RegionRegional scopeGlobal-North America, South America, APAC, Europe, ME&ACountry scopeUSA, Canada, Mexico, India, China, Japan, UK, Germany, France, Sweden, Brazil, Middle East, Turkey, AfricaKey companies profiled

Illumina Inc., Thermo Fisher Scientific, Perkinelmer, F. Hoffmann-La Roche AG (Roche), Pacific Biosciences, Agilent Technologies, 10x Genomics Inc, Qiagen

https://kymgl.com/reports/

#kymglobal #globalmarket #marketvalue #research #system #reports #globalreports #healthcare #technology #advancereport #report #kym #global #asia #usa #marketsize #Technology #segment #medicine #research #software #service #artificialintelligence #artificial #globalartificial #automotive

1 note · View note

market-research-industry · 4 years ago

Text

Nucleotides Market- Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2020– 2030

Nucleotides Market: Snapshot

Penetration of nucleotides in applications like nutraceuticals, pharmaceuticals, food and beverages additives, diagnostics research, and others may bring considerable growth for the global nucleotides market across the forecast period of 2020-2030. The use of nucleotides in increasing immunity is bringing tremendous growth opportunities for the nucleotides market.

Based on technology, the global nucleotides market can be classified into gene chips and microarrays, TaqMan allelic discrimination, SNP by pyrosequencing, and others. The expanding role of nucleotides in diagnosing viral infections and other diseases may serve as a prominent growth multiplier for the nucleotides market during the assessment period.

This report on the nucleotides market provides information to the stakeholder through the R.O.C.K (Regional Prospects. Overview. Competitive Dimensions. Key Trends) mechanism. This mechanism covers all the major prospects that are growth-worthy for the nucleotides market and helps the stakeholder to gain rock-solid insights.

The information included in this report has been designed after a scrutinized analysis on a variety of factors by an expert team of researchers. The report also offers insights into the COVID-19 impact on the nucleotides market and the prominent threats that the el nucleotides market may face between 2020 and 2030.

Request a Sample –

https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=79235

Nucleotides Market: Competitive Aspects

The nucleotides market can be classified as consolidated. A handful of companies acquire a large share of the nucleotides market by bringing expansive growth. New entrants in the nucleotides market are often merged with or acquired by the established players. Other activities such as joint ventures, collaborations, and partnerships are also conducted frequently.

Expansion of production facilities to cater to the ever-increasing demand for nucleotides is also a common element among the players in the nucleotides market. A strong network of raw material suppliers and vendors is necessary for smooth production. Therefore, the players are also engaged in networking with vendors and raw material suppliers.

Prominent participants in the nucleotides market are DSM Nutritional Products, CJ CheilJedang Corporation, NuEra Nutrition, Promega Corporation, ThermoFisher Scientific Inc, Biorigin, Lallemand Inc., Affymetrix Inc., Star Lake Bioscience Co., Inc, DSM Nutritional Products Ltd., F. Hoffman-La Roche Ltd, and Nanjing BioTogether Co., Ltd.

Nucleotides Market: Key Trends

With the evolution of biotechnology, the nucleotides market has transformed greatly over the years. The presence of novel and enhanced biotechnological technologies is bringing great advancements. The digital revolution is also helping the nucleotides market to gain good growth. Growing awareness among consumers regarding the benefits of nucleotides is creating ripples of growth. Nutritional premixes also contain nucleotides to a large extent. Hence, this aspect may invite tremendous growth for the nucleotides market.

A substantial number of individuals are realizing the ill-effects of savory ingredients. Nucleotides-based flavor enhancers serve as a perfect replacement for such ingredients. Hence, the rising awareness about the negative effects of savory ingredients may boost the growth rate of the nucleotides market to a great extent. The use of ribonucleotides in infant food formulations also brings extensive growth opportunities for the nucleotides market.

Request for covid19 impact analysis –

https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=79235

Nucleotides are also used for diagnosing viral infections and assists in finding novel insights into these infections and diseases. Nucleotides are also helping greatly in the fight against COVID-19, thus increasing the growth prospects of the nucleotides market.

Nucleotides Market: Geographical Insights

The nucleotides market is spread across North America, Latin America, the Middle East and Africa, Europe, and Asia Pacific. North America may serve as a prominent growth generator for the nucleotides market. Growing awareness about the merits associated with nucleotides may bring immense growth prospects for the nucleotides market. Rising disposable income is also helping in generating growth for the nucleotides market.

Europe may emerge as the second-largest growth contributor to the nucleotides market because of the escalating application scope in nutraceutical products across the region.

Pre-Book now-

https://www.transparencymarketresearch.com/checkout.php?rep_id=79235&ltype=S

This study by TMR is all-encompassing framework of the dynamics of the market. It mainly comprises critical assessment of consumers' or customers' journeys, current and emerging avenues, and strategic framework to enable CXOs take effective decisions.

Our key underpinning is the 4-Quadrant Framework EIRS that offers detailed visualization of four elements:

Customer Experience Maps

Insights and Tools based on data-driven research

Actionable Results to meet all the business priorities

Strategic Frameworks to boost the growth journey

The study strives to evaluate the current and future growth prospects, untapped avenues, factors shaping their revenue potential, and demand and consumption patterns in the global market by breaking it into region-wise assessment.

The following regional segments are covered comprehensively:

North America

Asia Pacific

Europe

Latin America

The Middle East and Africa

Companies in the Nucleotides market have increasingly shifted gears with wide application of digital technology across the continuum, from raw material sourcing to manufacturing to generation of final output, to warehousing to final distribution operations. Among the various affects, the market is witnessing new growth economics due to thinning of line between specialty and commodity businesses that are associated with the larger ecosystem. At the same time, new growth parameters are being vigorously being debated as industry stakeholders put greater emphasis on the circular economy processes.

More Trending Report-

https://www.prnewswire.com/news-releases/escalating-popularity-of-convenience-foods-to-attract-extensive-growth-opportunities-for-the-sorbic-acid-market-tmr-301265042.html

#Nucleotides Market

0 notes

wenickjones · 4 years ago

Text

Next Generation Sequencing (NGS) Market to See Huge Growth by 2026

Facto Market Insights recently published market research report on the Global Next Generation Sequencing (NGS) Market to its collection of market research reports. The research report covers detailed analysis of market sizing and forecasting of the market covering the market drivers, challenges, opportunity analysis, and trends, along with various key insights in the global market. The research report also includes the analysis of regional manufacturers and new market players, covering all the information suitable for the clients to make strategic business decisions in the industry.

Free Sample Report + All Related Graphs & Charts @

https://www.factomarketinsights.com/sample/31

The report covers PESTLE analysis and porter’s five forces analysis which demonstrates the five forces including buyers bargaining power, suppliers bargaining power, the threat of new entrants, the threat of substitutes, and degree of competition in the global next generation sequencing (ngs) market. In the study, the framework of porter's five forces analysis explains the method for analyzing the competition of the business covering the industry structure & the level of competition in the market. Along with this, the research report also covers the facts & figures related to the macroeconomic trends that are anticipated to impact the growth of the overall market.

In addition to this, the report also covers the section of competitive landscape of the global market, which includes the market share & positioning of all the leading players in the industry. The competitive landscape analysis provides in-depth analysis of the company’s business and performance including company overview, recent investments by top players, financial information of market players, business strategy, revenue breakup by segment and by geography, SWOT Analysis, key product offering, marketing and distribution strategies, new product development. A section of recent news & development has been added to the report which covers the latest information that are related with the market covering the acquisition, expansion, technology development, research & development activities, and other market activities.

Obtain Report Details @

https://www.factomarketinsights.com/report/31/next-generation-sequencing--ngs--market-amr

The Following are the Key Features of Global Next Generation Sequencing (NGS) Market Report:

Market Overview, Industry Development, Market Maturity, PESTLE Analysis, Value Chain Analysis

Growth Drivers and Barriers, Market Trends & Market Opportunities

Porter’s Five Forces Analysis & Trade Analysis

Market Forecast Analysis for 2020-2026

Market Segments by Geographies and Countries

Market Segment Trend and Forecast

Market Analysis and Recommendations

Price Analysis

Key Market Driving Factors

Next Generation Sequencing (NGS) Market Company Analysis: Company Market Share & Market Positioning, Company Profiling, Recent Industry Developments etc.

Market Segmentation:

The research offers a comprehensive analysis of global next generation sequencing (NGS) market with respect to following sub-markets:

By Product

o Consumables Sample Preparation Consumables§ • DNA Fragmentation, End Repair, A-Tailing and Size Selection • Library Preparation & Target Enrichment • Quality Control Other Consumables§ o Platforms HiSeq§ MiSeq§ Ion Torrent§ SOLiD§ Pacbio Rs II and Sequel System§ Other Sequencing Platforms§

o Services

Sequencing Services§ • RNA Sequencing • Whole Exome Sequencing • Whole Genome Sequencing • Targeted Sequencing • Chip Sequencing • De Novo Sequencing • Methyl Sequencing

Data Management Services§

NGS Data Analysis Services • NGS Data Analysis Software & Workbenches • NGS Storage, Management and Cloud Computing Solutions

By Application

o Diagnostics o Biomarkers and Cancer o Reproductive Health o Personalized Medicine o Agriculture and Animal Research o Other Applications

By Technology

o Sequencing by Synthesis o Ion Semiconductor Sequencing o Sequencing by Ligation o Pyrosequencing o Single Molecule Real Time Sequencing o Other Technologies

By End User

o Academic and Clinical Research Centers o Pharmaceutical and Biotechnology Companies o Hospitals and Clinics o Other End User

Regional Insights:

The report analyses the market by geographies i.e. North America, Europe, Asia Pacific, Latin America & Middle East & Africa. Further, the regions are fragmented into the country and regional groupings:

- North America (U.S. & Canada)

- Europe (Germany, United Kingdom, France, Italy, Spain, Russia, and Rest of Europe)

- Asia Pacific (China, India, Japan, South Korea, Indonesia, Taiwan, Australia, New Zealand, and Rest of Asia Pacific)

- Latin America (Brazil, Mexico, and Rest of Latin America)

- Middle East & Africa (GCC (Saudi Arabia, UAE, Bahrain, Kuwait, Qatar, Oman), North Africa, South Africa, and Rest of Middle East & Africa)

Competitive Analysis

The central members of the market are recorded in this segment of the examination. It assists with understanding the strategies and unions that players focus on battling market competition. A fundamental infinitesimal glance at the market is given in the essential investigation. The significant players working in the global next generation sequencing (NGS) market are:

Illumina, Inc. • Thermo Fisher Scientific, Inc. • Pacific Biosciences of California, Inc. • Beijing Genomics Institute • Qiagen N.V. • 454 Life Sciences Corporation (Roche Holding AG) • Agilent Technologies, Inc. • Perkinelmer, Inc. • Genomatix GmbH • PierianDx

Interested to Procure The Data? Inquire here at @

https://www.factomarketinsights.com/enquiry/31

About Us:

Facto Market Insights is one of the leading providers of market intelligence products and services. We offer reports on over 10+ industries and update our collection daily which helps our clients to access database of expert market insights on industries, companies, products, and trends.

Our in-house research experts have a wealth of knowledge in their respective domains. With Facto Market Research, you always have the choice of getting customized report free of cost (upto 10%). Our support team will help you customize the report and scope as per your business needs. This ensures that you are making the right purchase decision.

Our clients list includes various Fortune 500 companies and leading advisory firms.

Facto Market Insights

90 State Street, Albany,

New York, USA 12207

+1 (518) 250-1215

Email:[email protected]

Website: www.factomarketinsights.com

0 notes

jeffzadoks · 5 years ago

Text

Precision Medicine Market: Future Scope, Revenue Growth, Global Market Size, Market Status, Top key players, end of 2027

Recent report published by research nester titled “Precision Medicine Market: Global Demand Analysis & Opportunity Outlook 2027”delivers the detailed overview of the global precision medicine market in terms of market segmentation by product, by technology, by sequencing technology, by application, by end user and by region.

Further, for the in-depth analysis, the report encompasses the industry growth drivers, restraints, supply and demand risk, market attractiveness, BPS analysis and Porter’s five force model.

The global precision medicine market can be segmented on the basis of product, technology, sequencing technology, application, end user and region. On the basis of product, it is sub-segmented into instruments, consumables and services. Based on technology, it is sub-segmented into transcriptomics, genomics and epigenomics. On the basis of sequencing technology, it is sub-segmented into ion semiconductor sequencing, pyrosequencing, single molecule real time Sequencing, chain termination sequencing, sequencing by synthesis, sequencing by ligation and nanopore sequencing. CLICK TO DOWNLOAD SAMPLE

Based on application, it is sub-segmented into immunology, CNS, oncology, respiratory medicine, infections and others. On the basis of end user, it is sub-segmented into pharma & biotech companies, diagnostic tool companies, big data companies and clinical laboratories. The market across the globe is exclusively focusing to provide specific tailored treatments to patients are also concentrating on proving the best possible treatment for cancer patients. These factors are anticipated to boost the growth of the global precision medicine market in upcoming years.

The global precision medicine market is anticipated to expand at a CAGR around 10.6% during 2019-2027. Increment in the growth of personal healthcare devices along with rise in investment in the research and development is expected to augment the market shares. Further, the rapid development in the field of bioinformatics combined with high adoption rate of gene therapy are some of the significant factors that are estimated to positively affect the growth of the market.

By region, the global precision medicine market is segmented into North America, Asia-Pacific, Latin America, Europe, Middle East and Africa. Among these region, North America is expected to dominate the global market of precision medicine on account of increasing cases related to rare genetic disorders and various initiatives taken by the regulatory bodies in support of the market. Further, the rising investment in the research and development in the field of precision medicine coupled with rising healthcare infrastructure are some of the factors that are augmenting the growth of market in this region. In the Europe region, Germany is expected to have the largest market share on the back of rising pediatric and adult population susceptible to metabolic diseases. Additionally, rising investment in the healthcare sector by various private and government organizations coupled with various technological advancements in this field is anticipated to boost the market growth over the forecast period.

Vibrant Growth of Precision Medicine

Rapid development in the field of bioinformatics, increasing growth of personal healthcare devices, growing rate of improvement in the field of targeted therapies and higher adoption rate of gene therapy is anticipated to drive the global precision market over the forecast period.

However, the security issues associated with the handling of large volume of genetic sequenced data might hinder the growth of the market during the forecast period.

This report also provides the existing competitive scenario of some of the key players of the global precision medicine market which includes company profiling of key companies such as Bristol-Myers Squibb, Eli Lilly & Company, Roche Holding AG, Illumina Inc., Thermo Fisher Scientific Inc., Novartis AG, AstraZeneca, QIAGEN, Quest Diagnostics, Pfizer Inc. CLICK TO DOWNLOAD SAMPLE

The outlining enfolds key information of the companies which encompasses business overview, products and services, key financials and recent news and developments. On the whole, the report depicts detailed overview of the global precision medicine market that is expected to help industry consultants, equipment manufacturers, existing players searching for expansion opportunities, new players searching possibilities and other stakeholders to align their market centric strategies according to the ongoing and expected trends in the future.

0 notes

ajaychandak01 · 5 years ago

Text

Nucleotide Market Likely to Emerge over a Period of 2020 - 2027: Ajinomoto Co., Inc., Star Lake Bioscience Co., Inc., CJ CheilJedang Corporation,, etc.

Industry Overview of the Nucleotide Market

The Global Nucleotide Market is witnessing a remarkable growth owing to an increase in the demands for the products and a tremendous shift in consumer preferences. The high demand is concentrated in the European and North American countries. The report on Global Nucleotide Market offers a comprehensive analysis of the recent advancements in the Nucleotide industry and trends driving the growth of the market. The industry is expected to grow at a rate of XX% CAGR during the forecast period from 2020-2027. The report offers the segmentation of the market on the basis of types, applications, and regions. The report is updated with the latest trends and economic scenario owing to the COVID-19 pandemic. The impact analysis of the pandemic is described in the report. A comprehensive analysis of the present and future impact of COVID-19 on the market, along with a post-COVID-19 scenario, is included in the report.

Get a sample of the report @ https://www.reportsanddata.com/sample-enquiry-form/3368

On the basis of regional analysis, the market is segmented into key geographical regions such as North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. According to the analysis, North America is expected to dominate the market with the highest market share. Asia-Pacific is anticipated to show a significant growth rate owing to rising development and population demands.

Some of the key players operating in the Nucleotide market include:

Ajinomoto Co., Inc., Star Lake Bioscience Co., Inc., CJ CheilJedang Corporation, Ohly GmbH, Lallemand Inc., ThermoFisher Scientific Inc., NuEra Nutrition,Promega Corporation, Nanjing BioTogether Co., Ltd., and Affymetrix Inc among others.

Product Outlook (Revenue, USD Billion; 2017-2027)

Food Grade

Lab Grade

Industry Grade

Technology Outlook (Revenue, USD Billion; 2017-2027)

TaqMan allelic discrimination

Gene chips & microarrays

SNP by pyrosequencing

Others

Application Outlook (Revenue, USD Billion; 2017-2027)

Pharmaceuticals

Diagnostics research

Food & beverage additive

Animal feed additive

Others

Request a discount on the report @ https://www.reportsanddata.com/discount-enquiry-form/3368

Beneficial Aspects of the Report:

· Global and region forecast of the Nucleotide market from 2020-2027

· In-depth analysis of market dynamics, industry outlook, market size based on types and applications

· Details of value chain analysis, supply and demand ratio, production and consumption patterns

· SWOT Analysis, Porter’s Five Forces Analysis, Feasibility Analysis, and Investment Return Analysis to provide a better understanding of the market and competitive players

· Detailed insights on competitive landscape and emerging market trends

Research Methodology:

The market report is formulated on the basis of data obtained through extensive primary and secondary research. The data is further validated and verified by industry experts, research analysts, and professionals. The report considers regional demand and supply ratio, investments, market dynamics, capacity, end-use industry trends, and consumer behavior to generate a forecast report. The data is collected from verified sources such as government policies, regulatory published materials, journals, trade magazines, and verified data sources. The report uses advanced analytical tools such as SWOT Analysis, Porter’s Five Forces Analysis, Feasibility Analysis, and Investment Return Analysis to provide an accurate insight into the market scenario and competitive landscape. This report provides beneficial information to companies and new players to make lucrative business decisions. The market estimates and forecast data have been thoroughly verified through exhaustive primary research.

To read more about the report – https://www.reportsanddata.com/report-detail/nucleotide-market

Thank you for reading our report. Reports and Data provides customization of the report as per the needs of the clients. For further inquiry on customization, please connect with us and our team will ensure the report is tailored to fit your requirements.

About Us: Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client’s make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Power and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market. Contact Us: John Watson Head of Business Development Direct Line: +1-212-710-1370 E-mail: [email protected] Reports and Data | Web: www.reportsanddata.com News: www.reportsanddata.com/market-news Connect with us: Facebook | LinkedIn | Twitter

#Nucleotide Market

0 notes

newsresearch · 6 years ago

Text

Next Generation Sequencing (NGS) Market is Growing at a CAGR of 22.7% in 2024

Next Generation Sequencing (NGS) Market accounted to USD 13.51 billion by 2022 growing at a CAGR of 22.7% during the forecast period of 2017 to 2024. The upcoming market report contains data for historic years 2015, the base year of calculation is 2016 and the forecast period is 2017 to 2024.

Next Generation Sequencing (NGS) Market is also termed as high-throughput sequencing. It is a DNA sequencing technology in which millions and billions DNA strands are sequenced. It has revolutionized genomic research, as it minimizes the requirement for fragment-cloning methods used in Sanger sequencing of genomes.

Major Market Competitors: Global Next Generation Sequencing (NGS) Market

Some of the major players operating in Global Next Generation Sequencing (NGS) Market are Illumina, Inc., Thermo Fisher Scientific Inc., Pacific Biosciences of California, Inc., QIAGEN, BGI, Oxford Nanopore Technologies, PerkinElmer, Inc., GATC Biotech AG, Agilent Technologies, F. Hoffmann-La Roche Ltd, Macrogen, Inc., Eurofins Scientific, Biomatters Limited, Genomatix GmbH, PierianDx, Myriad Genetics, Inc., Partek Incorporated, DNASTAR, Inc., New England Biolabs among others.

Download PDF Sample report @ https://databridgemarketresearch.com/request-a-sample/?dbmr=global-next-generation-sequencing-ngs-market

Competitive Analysis: Global Next Generation Sequencing (NGS) Market

The Next Generation Sequencing (NGS) Market is highly fragmented and is based on new product launches and clinical results of products. Hence the major players have used various strategies such as new product launches, clinical trials, market initiatives, high expense on research and development, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of Global Next-Generation Sequencing (NGS) Market for global, Europe, North America, Asia Pacific and South America.

Major Market Drivers and Restraints:

· Advanced technology in NGS platforms and increased applications of NGS.

· Increased in adoption of NGS among research laboratories and academic institutes.

· Efficient speed, cost, and accuracy of the technology.

· Drug discovery applications in NGS technology are some of the factors which drives the market.

· R&D investments are another factor to grow the market.

· Lack of skilled technicians.

· Accuracy and uniformity concerns in diagnostics testing limits the growth of market.

· Interpretation of complex data and issues regarding storage of sequencing data hinders the market.

· Legal and ethical issues are the challenge in the growing market.

· Emerging markets are proving the new opportunities in the growth of the market.

· Application of NGS in precision medicines & Biomarker discovery.

Want Full Report? Enquire Here @ https://databridgemarketresearch.com/inquire-before-buying/?dbmr=global-next-generation-sequencing-ngs-market

Market Segmentation: Global Next Generation Sequencing (NGS) Market

The Next Generation Sequencing (NGS) Market is segmented in Product and Services, which is segmented in Consumables, which is further bifurcated in Sample Preparation, which is again further classified in DNA Fragmentation, End Repair, A-Tailing, and Size Selection, Library Preparation & Target Enrichment, Quality Control and other consumables, Platforms, which is classified in HiSeq, MiSeq, Ion Torrent, SOLiD, Pacbio Rs II and Sequel System and other sequencing platforms, Sequencing Services, which is classified in RNA Sequencing, Whole Exome Sequencing, Whole Genome Sequencing, Targeted Sequencing, Chip Sequencing, De Novo Sequencing, Methyl Sequencing, Amplicon sequencing, Epigenomics, Digital Karyotyping and Metagenomics, Data Managemnet Services, which is further bifurcated in NGS Data Analysis Services, NGS Data Analysis Software & Workbenches, NGS Storage, Management and Cloud Computing Solutions.

· By Technology the NGS market is segmented in Sequencing by Synthesis, Ion Semiconductor Sequencing, Sequencing by Ligation, Pyrosequencing, Single Molecule Real Time Sequencing.

· By Application the market is classified in Diagnostics, Drug Discovery, Biomarker Discovery, Precision Medicine, Agriculture and Animal Research, Reproductive Health, Personalized Medicine, Oncology, Clinical Investigation, Forensics,. HLA typing/Immune System Monitoring, Metagenomics, Epidemiology.

· By End Users the market is spread in Hospitals & Healthcare institutions, Biotech & Pharma firms, Academic & Government Research Institutes, Pharmaceutical Companies, Biotechnology Companies, Clinical Research.

· By Geography the market covers the 5 major regions such as North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa.

Reasons to Purchase this Report

· Current and future of global dermatology drugs market outlook in the developed and emerging markets

· The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period

· Regions/Countries that are expected to witness the fastest growth rates during the forecast period

· The latest developments, market shares, and strategies that are employed by the major market players

Speak to Author @ https://databridgemarketresearch.com/speak-to-analyst/?dbmr=global-next-generation-sequencing-ngs-market

About Us:

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge Market Research provides appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

Contact:

Data Bridge Market Research

Tel: +1-888-387-2818

Email: [email protected]

#Next Generation Sequencing (NGS) Market #Next Generation Sequencing (NGS)#Next Generation Sequencing (NGS) Market Trends #Next Generation Sequencing (NGS) Market Industry #Next Generation Sequencing (NGS) Market News

0 notes

shraddhasarvankar · 6 years ago

Text

Global Transfusion Diagnostics Market and Sales Segment Forecasts

This comprehensive 68-country report provides granular data and analysis not available from any other source. Global Transfusion Diagnostics Market report is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the global blood banking market during the next five years, and assist industry executives in developing effective business, new product development and marketing strategies.

The report explores future market and technological trends; provides test volume and sales forecasts by market segment/test location; compares features of major automated and semi-automated molecular and immunohematology analyzers; profiles leading and emerging competitors; and identifies specific product and market opportunities facing suppliers during the next five years.

Blood Group Genotyping

PCR, PCR-RFLP, AS-PCR or PCR-SSP, Multiplex PCR, Real Time PCR, Sanger DNA Sequencing, Pyrosequencing

Microarrays

BeadChip Array, BloodChip, Genome Lab SNP Stream, Fluidic Microarray Systems, TaqMan OpenArray, MALDI-TOF-MS, Mini-Sequencing

Blood Typing and Grouping Tests

ABO, Antibody Panels, Antibody Screening/Indirect Antiglobulin, Antigen Typing (C, c, Duffy, E, e, I, i, Kell, Kidd, Le a, b, MN, P, S, s), Antiglobulin (Direct, C3 + IgG, IgG, C3), Crossmatching (Immediate Spin, Full Crossmatch), Rh (D, Du). Infectious Disease Screening Tests AIDS (HIV NAT, HIV-1/2), Cytomegalovirus, Hepatitis (HAV NAT, HBV NAT, HBs Ag, Anti-HBc, HCV NAT, HCV, ALT/SGPT), HTLV-I/II, Parvovirus B19 NAT, Syphilis, West Nile Virus NAT.

Geographic Regions

Africa, Asia-Pacific, Europe, Latin America, Middle East, North America Country Analyses

Argentina, Australia, Austria, Bahrain, Bangladesh, Belgium, Brazil, Bulgaria, Canada, Chile, China, Colombia, Croatia, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hong Kong, Hungary, Iceland, India, Indonesia, Iran, Iraq, Ireland, Israel, Italy, Japan, Jordan, Kuwait, Latvia, Lebanon, Lithuania, Malaysia, Malta, Mexico, Myanmar, Netherlands, New Zealand, Norway, Oman, Pakistan, Peru, Philippines, Poland, Portugal, Qatar, Romania, Saudi Arabia, Serbia, Singapore, Slovakia, Slovenia, South Korea, Spain, Sweden, Switzerland, Taiwan, Thailand, UK, United Arab Emirates, USA, Venezuela, Vietnam

Market Segmentation Analysis

- Comprehensive market segmentation analysis, including review of the market dynamics, trends, structure, size, growth, and key suppliers. - Test volume and sales forecasts for over 40 blood typing, grouping and infectious disease screening tests, including NAT assays.

Current and Emerging Products

- Analysis of current and emerging molecular blood typing, grouping and infectious disease NAT screening assays. - Review of automated and semi-automated molecular and immunohematology analyzers. Category: Healthcare Market Research Aarkstore Enterprise +91 9987295242 | [email protected] | www.aarkstore.com

#GlobalTransfusionDiagnosticsMarket #TransfusionDiagnosticsMarket #TransfusionDiagnosticsMarketReport

0 notes

healthcaremarkettrend · 6 years ago

Text

Tumor Profiling Market Projected to Show Strong Growth, Expanded Technology by 2022

The report "Tumor Profiling Market by Application (Clinical, Research), Technology (Immunoassay, Hybridization (PCR, In Situ Hybridization, DNA/RNA Microarray), NGS, Mass Spectrometry), Cancer Type (Breast, Lung, Prostate, Colorectal) - Global Forecast to 2022", Tumor Profiling Market is projected to reach USD 8.74 Billion by 2022 from USD 5.26 Billion in 2017, at a CAGR of 10.7%.

Download PDF Sample Pages of Tumor Profiling Market @: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=1250

Major factors fueling the growth of the market include increasing number of cancer cases across the globe, the increasing utility of biomarkers, and availability of funding for cancer research. On the other hand, high capital investments and low benefit ratio for biomarkers used in cancer/tumor profiling are expected to limit the cancer/tumor profiling market growth to a certain extent. Factors such as the increasing demand for personalized medicine and point-of-care diagnostic tests in cancer/tumor profiling are expected to offer a wide range of growth opportunities for players in the cancer/tumor profiling market.

Scope of the Report

This research report categorizes the global market on the basis of technology, cancer type, application, and region

Global Tumor Profiling Market, by Application

Clinical Applications

Research Applications

Global Tumor Profiling Market, by Technology

Immunoassays

Hybridization

Next-generation Sequencing

Mass Spectroscopy

Other Technologies (Pyrosequencing and Sanger Sequencing)

Global Tumor Profiling Market, by Cancer Type

Breast Cancer

Lung Cancer

Colorectal Cancer

Prostate Cancer

Melanoma Cancer

Other Cancer Types (Non-Hodgkin’s Lymphoma, Melanoma, Leukemia, Thyroid, Bladder, and Kidney)

Global Tumor Profiling Market, by Region

Canada

Speak with our Experts @: https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=1250

Major players operating in the cancer profiling market include Illumina (US), QIAGEN (Netherlands), NeoGenomics Laboratories (US), HTG Molecular Diagnostic (US), and Genomic Health (US). These players focus on inorganic strategies such as acquisitions, agreements, and collaborations as well as organic strategies such as product launches and expansions to sustain their growth in the tumor profiling market.

Other major players in the market include Caris Life Sciences. (U.S.), Helomics Corporation (U.S.), and NanoString Technologies, Inc. (U.S.).

Objectives of the Study

To define, describe, and forecast the tumor profiling market on the basis of application, technology, cancer type, and region

To provide a detailed information regarding the major factors influencing the growth of the market (drivers, restraints, opportunities, and challenges)

To strategically analyze micromarkets with respect to individual growth trends, prospects, and contribution to the total market

To analyze the opportunities in the market for stakeholders and details of a competitive landscape for market leaders

To forecasting the revenue of market segments with respect to four main geographies (along with countries), namely, North America, Europe, Asia Pacific, and the RoW

To profile key players and comprehensively analyze their market shares and core competencies

To track and analyze competitive developments such as collaborations, new product developments, product enhancements, and R&D activities in the tumor profiling market

Get Sample Report with all Graphs & Charts related to it @: https://www.marketsandmarkets.com/requestsampleNew.asp?id=1250

About MarketsandMarkets™:

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, and strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledge Store" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact:

Mr. Shelly Singh

MarketsandMarkets™ INC.

630 Dundee Road

Suite 430

Northbrook, IL 60062

USA: 1-888-600-6441

Email: [email protected]

#Tumor Profiling Market Growth #Tumor Profiling Market Share #Tumor Profiling Market Size #Tumor Profiling Market Trends #global Tumor Profiling Market #Tumor Profiling Asia Pacific market #Tumor Profiling Europe market #Tumor Profiling market #Tumor Profiling market Future #Tumor Profiling market in Key Countries #Tumor Profiling Market Latest Report #Tumor Profiling market report 2018 #Tumor Profiling market SWOT analysis #Tumor Profiling market Top Manufacturers #Tumor Profiling Sales market #Tumor Profiling United States market #global Tumor Profiling market by Application #global Tumor Profiling Market by rising trends

0 notes

reporthive-blog · 8 years ago

Text

United States SNP Genotyping and Analysis Market Report 2017

In this report, the United States SNP Genotyping and Analysis market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions: The West Southwest The Middle Atlantic New England The South The Midwest with sales (volume), revenue (value), market share and growth rate of SNP Genotyping and Analysis in these regions, from 2012 to 2022 (forecast).

Request a sample of this report @ https://www.reporthive.com/enquiry.php?id=1048773&req_type=smpl

United States SNP Genotyping and Analysis market competition by top manufacturers/players, with SNP Genotyping and Analysis sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including Illumina Roche Life Technologies Corporation Sequenom Affymetrix Fluidigm

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into SNP GeneChips and Microarrays Taqman Allelic Discrimination SNP by Pyrosequencing AB SNPlex MassARRAY MALDI-TOF Others

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of SNP Genotyping and Analysis for each application, including Pharmaceuticals and Pharmacogenomics Diagnostic Research Agricultural Biotechnology Breeding and Animal Livestock

If you have any special requirements, please let us know and we will offer you the report as you want.

Enquiry For Discount @ https://www.reporthive.com/enquiry.php?id=1048773&req_type=disc

Table of Contents

1 SNP Genotyping and Analysis Overview 1.1 Product Overview and Scope of SNP Genotyping and Analysis 1.2 Classification of SNP Genotyping and Analysis by Product Category 1.2.1 United States SNP Genotyping and Analysis Market Size (Sales Volume) Comparison by Type (2012–2022) 1.2.2 United States SNP Genotyping and Analysis Market Size (Sales Volume) Market Share by Type (Product Category) in 2016 1.2.3 SNP GeneChips and Microarrays 1.2.4 Taqman Allelic Discrimination 1.2.5 SNP by Pyrosequencing 1.2.6 AB SNPlex 1.2.7 MassARRAY MALDI-TOF 1.2.8 Others 1.3 United States SNP Genotyping and Analysis Market by Application/End Users 1.3.1 United States SNP Genotyping and Analysis Market Size (Consumption) and Market Share Comparison by Application (2012–2022) 1.3.2 Pharmaceuticals and Pharmacogenomics 1.3.3 Diagnostic Research 1.3.4 Agricultural Biotechnology 1.3.5 Breeding and Animal Livestock 1.4 United States SNP Genotyping and Analysis Market by Region 1.4.1 United States SNP Genotyping and Analysis Market Size (Value) Comparison by Region (2012–2022) 1.4.2 The West SNP Genotyping and Analysis Status and Prospect (2012–2022) 1.4.3 Southwest SNP Genotyping and Analysis Status and Prospect (2012–2022) 1.4.4 The Middle Atlantic SNP Genotyping and Analysis Status and Prospect (2012–2022) 1.4.5 New England SNP Genotyping and Analysis Status and Prospect (2012–2022) 1.4.6 The South SNP Genotyping and Analysis Status and Prospect (2012–2022) 1.4.7 The Midwest SNP Genotyping and Analysis Status and Prospect (2012–2022) 1.5 United States Market Size (Value and Volume) of SNP Genotyping and Analysis (2012–2022) 1.5.1 United States SNP Genotyping and Analysis Sales and Growth Rate (2012–2022) 1.5.2 United States SNP Genotyping and Analysis Revenue and Growth Rate (2012–2022)

2 United States SNP Genotyping and Analysis Market Competition by Players/Suppliers 2.1 United States SNP Genotyping and Analysis Sales and Market Share of Key Players/Suppliers (2012–2017) 2.2 United States SNP Genotyping and Analysis Revenue and Share by Players/Suppliers (2012–2017) 2.3 United States SNP Genotyping and Analysis Average Price by Players/Suppliers (2012–2017) 2.4 United States SNP Genotyping and Analysis Market Competitive Situation and Trends 2.4.1 United States SNP Genotyping and Analysis Market Concentration Rate 2.4.2 United States SNP Genotyping and Analysis Market Share of Top 3 and Top 5 Players/Suppliers 2.4.3 Mergers & Acquisitions, Expansion in United States Market 2.5 United States Players/Suppliers SNP Genotyping and Analysis Manufacturing Base Distribution, Sales Area, Product Type